RM

Richard Mason

Chief Executive Officer

Apollo Therapeutics

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Apollo Therapeutics
Industry
research
Employees
60.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
405000000.0
Latest Funding
Series C

Technologies

Cloudflare DNS Outlook Microsoft Office 365 Amazon AWS Salesforce Google Tag Manager WordPress.org reCAPTCHA Mobile Friendly Apache Hotjar Varnish Google Font API Nginx Bootstrap Framework Google Analytics Python IoT AI

Keywords

biotechnology biopharmaceuticals therapeutics oncology major inflammatory disorders rare disease biotechnology research biopharmaceutical drug discovery innovative medicines drug development clinical trials portfolio management capital efficiency biotech r&d platform academic partnerships first-in-class best-in-class preclinical development human biology translational studies small molecules monoclonal antibodies genetic research immunology pulmonary hypertension atopic dermatitis vast pipeline therapeutic innovation drug candidates ind enabling scientific breakthroughs biomedical research research institutions collaboration pharmaceutical companies treatment modalities therapeutic programs protocols medical research clinical development therapeutic areas disease mechanisms staff expertise scientific access pharma partnerships research collaborations biomedical advancements team culture truth-seeking organizational strategy drug candidates selection medical advancements pharmacology hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans